Nectero Medical is developing a novel treatment to stabilize growth and prevent rupture of mid-sized abdominal aortic aneurysms (AAA). The Nectero EAST®, or Endovascular Aneurysm Stabilization Treatment System, delivers a compound with a proprietary molecule known as a Stabilizer Agent to the site of the aneurysm. 

The Stabilizing Agent:
* Inhibits further breakdown of the aneurysm by disrupting the “aortic degradation process”.

* Strengthens the vessel wall by cross-linking within the tissue; this wall strengthening lowers the risk of rupture.

Our technology allows for earlier intervention in a much safer manner; this can prevent or significantly delay the need for major endovascular (EVAR) or surgical repair.

By preventing further degradation of the aneurysm and strengthening the aortic tissue around the aneurysm, many patients can live out their normal life span and never need to face the challenges  of EVAR or Surgical repair.

Boston Scientific

Nectero Medical, Inc.

Cardurion is a company specializing in healthcare solutions, focusing on cardiovascular medical devices and technologies.

Cardurion

XyloCor is a healthcare company that specializes in developing advanced medical devices and technologies for cardiac care and treatment.

XyloCor

Renova Therapeutics is a biotech company focused on developing innovative therapies for various medical conditions, including cardiovascular and metabolic diseases.

Renova Therapeutics

NeoLight is a medical technology company specializing in neonatal care, providing innovative solutions for infant health and well-being.

NeoLight

Nano Hearing Aids is a company dedicated to providing high-quality hearing aids and related technologies to improve the hearing health of individuals.

Nano Hearing Aids

Symple Surgical is a medical devices company specializing in developing simple and effective surgical solutions for various medical procedures.

Symple Surgical

Nectero Medical is a company that specializes in providing healthcare solutions, with a focus on medical devices and technologies designed to improve patient care and outcomes.

Nectero Medical

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Jun 22, 2024 11:03 AM	400e8857
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	Jun 22, 2024 5:53 PM	020deab7
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Jun 22, 2024 11:03 AM	c7931acb
translate crunchbase fundingrounds	general
peers	general
news basic	general	Jun 22, 2024 11:03 AM	271a0886
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:NECTEROMEDICAL

Nectero Medical